Farris Maryanne Maunsell - 05 Jun 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
VP, Chief Accounting Officer
Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Farris
Issuer symbol
HAE
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 16:49:43 UTC
Previous filing
20 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maunsell Farris Maryanne VP, Chief Accounting Officer 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Ms. Farris 09 Jun 2025 0001950052

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2,662 +147% 4,478 05 Jun 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F3 This number includes unvested RSUs previously reported.